Finance

Lists
1801:HKG
Innovent Biologics Inc
89,05 HK$
+1,48%
(+1,30) 1D
16 հոկ, 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1801...
Open
91,25 HK$
High
92,45 HK$
Low
88,00 HK$
Mkt. cap
155,56 մլրդ
Avg. vol.
9,91 մլն
Volume
9,69 մլն
P/E ratio
111,08
52-wk high
112,70 HK$
52-wk low
69,55 HK$
EPS
0,80 HK$
No. of employees
9 հզր
Open
91,25 HK$
High
92,45 HK$
Low
88,00 HK$
Mkt. cap
155,56 մլրդ
Avg. vol.
9,91 մլն
Volume
9,69 մլն
P/E ratio
111,08
52-wk high
112,70 HK$
52-wk low
69,55 HK$
EPS
0,80 HK$
No. of employees
9 հզր
News stories
From web sources and news partners
Profile
Innovent Biologics, Inc. is a publicly listed Chinese biopharmaceutical company that is headquartered in Suzhou, Jiangsu. Wikipedia
About Innovent Biologics Inc
CEOMichael Yu
Employees8,75 հզր
Founded28 նոյ, 2011 թ.
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
3,54 մլրդ
3,54 մլրդ
4,31 մլրդ
4,31 մլրդ
Cost of goods sold
845,12 մլն
845,12 մլն
999,35 մլն
999,35 մլն
Cost of revenue
845,12 մլն
845,12 մլն
999,35 մլն
999,35 մլն
Research and development expenses
807,71 մլն
807,71 մլն
841,85 մլն
841,85 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,91 մլրդ
1,91 մլրդ
1,86 մլրդ
1,86 մլրդ
Operating expense
2,72 մլրդ
2,72 մլրդ
2,71 մլրդ
2,71 մլրդ
Total operating expenses
3,56 մլրդ
3,56 մլրդ
3,71 մլրդ
3,71 մլրդ
Operating income
-19,96 մլն
-19,96 մլն
602,76 մլն
602,76 մլն
Other non operating income
45,19 մլն
45,19 մլն
31,56 մլն
31,56 մլն
EBT including unusual items
-29,10 մլն
-29,10 մլն
805,83 մլն
805,83 մլն
EBT excluding unusual items
-1,59 մլն
-1,59 մլն
738,07 մլն
738,07 մլն
Income tax expense
-18,72 մլն
-18,72 մլն
179,26 մլն
179,26 մլն
Effective tax rate
64,33%
64,33%
22,25%
22,25%
Other operating expenses
-
-
-
-
Net income
-10,38 մլն
-10,38 մլն
626,57 մլն
626,57 մլն
Net profit margin
-0,29%
-0,29%
14,54%
14,54%
Earnings per share
-
-
-
-
Interest and investment income
124,16 մլն
124,16 մլն
178,13 մլն
178,13 մլն
Interest expense
-9,17 մլն
-9,17 մլն
-20,46 մլն
-20,46 մլն
Net interest expenses
114,99 մլն
114,99 մլն
157,67 մլն
157,67 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
140,29 մլն
140,29 մլն
761,42 մլն
761,42 մլն
Gain or loss from assets sale
-71,00 հզր
-71,00 հզր
1,36 մլն
1,36 մլն
AI content may include mistakes. Learn more
Google Apps